English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Regional anesthesia for pain at delivery in the presence of maternal thrombocytopenia is a clinical dilemma. We reviewed 10,369 obstetric cases (12 months) from our tertiery center. Generally, hemodilution of pregnancy does not result in thrombocyte counts of &lt;150,000/mm 3  at delivery. A total of 166 births (1.6%) were recorded in women with thrombocytes &lt;150,000/mm 3  at delivery. Parturients with &gt;150,000/mm 3  at week 36 were separated  post hoc  (n=35; 21%) and the remaining parturients were divided as having &lt;100,000/mm 3  (n=30; 18%) or 101,000–150,000/mm 3  (n=101; 60.5%). Epidural or spinal anesthesia was administered to 30% women with &lt;100,000/mm 3  whereas 56% women with &gt;101,000/mm 3  received these options (P=0.003). A total of 13.9% of parturients with trimester-long thrombocytopenia required blood products; 10/23 (43.5%) parturients undergoing cesarean section also required blood products (P=0.000). Four of six babies with Apgar scores of ≤7 at 1-min were born to women with platelets &lt;100,000/mm 3  (P=0.009). There were no statistically significant differences in mean birth weights. Women with thrombocytes &lt;150,000/mm 3  at birth but within the normal range at week 36 were more likely multiparas (P=0.001). We conclude that a difference in maternal and neonatal outcomes exists between mothers who were thrombocytopenic only at delivery compared to those with trimester-long thrombocytopenia, with the latter mothers and babies having more adverse events.

Retrospective audit of outcome of regional anesthesia for delivery in women with thrombocytopenia